关注
vatsala singh
vatsala singh
Sr Research Professional, University of Colorado Anschutz Medical Campus
在 cuanschutz.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
C Baker, C Retzik-Stahr, V Singh, R Plomondon, V Anderson, N Rasouli
Therapeutic advances in endocrinology and metabolism 12, 2042018820980225, 2021
992021
Should metformin remain the first-line therapy for treatment of type2 diabetes. Therapeutic Advances in Endocrinology and Metabolism 2021; 12
C Baker, C Retzik-Stahr, V Singh, R Plomondon, V Anderson, N Rasouli
5
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus
S Rella, J Onyiah, C Baker, V Singh, A Her, N Rasouli
Therapeutic Advances in Endocrinology and Metabolism 14, 20420188231207348, 2023
12023
系统目前无法执行此操作，请稍后再试。
文章 1–3